Clinics
Age and sex: 28 years old female patient. Previous History: -no preleukemia; -no previous malignant disease; -no inborn condition of note. Organomegaly: -no hepatomegaly; -no splenomegaly; -no enlarged lymph nodes; -no central nervous system involvement.
Blood
Blasts: 52% 
Cytopathology classification

Comments
Chromosomal rearrangement between 11p15 and 20q11 has been reported in hematologic malignancies (Lam and Aplan, 2001) , which results in fusion of the nucleoporin gene, NUP98 on chromosome 11p15 with topoisomerase 1, TOP1 gene located at 20q11. The NUP98 is a member of nuclear pore complex and involved in nuclear-cytosolic transport of RNA and protein complexes, and TOP1 is a protein whose cterminus site of active tyrosine forms phosphodiester bond with 3'-strand of DNA and generates transient single strand DNA breaks (Wang 2002). In t(11; 20) , the rearrangement generates NUP98-TOP1 fusion protein from fusion of N-terminal portion of NUP98 20)(p15; q11) detected in AML M0: A case report Ganguly BB, et al. Atlas Genet Cytogenet Oncol Haematol. 2008; 12(1) 86 G-banding shows t(11;20)(p15;q11); Interphase FISH with three signals of chromosome 11.
514) with most of TOP1 gene (170-765), including core, linker and catalytic domains (Gurevich et al. 2004) . It has been suggested that the NUP98-TOP1 has leukemogenic activities independent of topoisomerase activity. The t(11;20) has also been described in patients with polycythemia vera, T-MDS and acute myeloid leukemia (Chen et al. 2003 , Potenza et al. 2004 , Panagopoulos et al. 2002 . Our case aged 28 years with 60 kg weight has been reported with AML-M0 and probable NUP98 and TOP1 fusion. In addition, del(3p), inv(X) and der(7) was observed in one single cell. Short survival of 2.5 -30 months was reported after diagnosis (Sekikawa and Horiguchi-yamada, 2005) . Our patient got the shortest survival of 23 days after diagnosis
